The typical OTC pinkies dilute by taking out toxic financing, supposedly to finance their companies endeavors. What actually happens is that the company takes the money to pay themselves with no intent to develop the company. When the loan is due they pay the toxic financier with a few hundred million shares at a huge discount. The toxic financier then dumps the shares on the market, thus making a big profit as the pps gets driven down. The pnd company does this over and over until a company ends up with a float of a few billion shares and a pps at .0001. This is typically the death nell. Those in the company know this. They max out the A/S, stop filing, and then get delisted. I've seen it many times. But MGON is not a pnd company. That's what makes it so attractive.
News 
Market Data 
Discover 
AI
